Published in:
01-01-2020 | Concise Research Report
Extended-Release Formulation and Medication Adherence
Authors:
John A. Romley, PhD, Zhiwen Xie, MA, Tommy Chiou, BA, Dana Goldman, PhD, Anne L. Peters, MD
Published in:
Journal of General Internal Medicine
|
Issue 1/2020
Login to get access
Excerpt
Suboptimal adherence to chronic medications undermines treatment effectiveness and costs the USA as much as $289 billion annually.
1 Prescription of extended-release (XR) formulations may offer a partial solution, as past studies have found that XR formulations can improve adherence.
2 However, the majority of past studies have analyzed adherence to XR formulations only in the context of specific medications and short-term time frames (< 1 year).
3, 4 This study investigates the effects of XR on long-term (≥ 1 year) adherence across 15 chronic medications, as well as the influence of cost-sharing on XR usage. …